We are monitoring the impact of COVID-19 on MEA RIA Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 3560
Share on
Share on

Middle East & Africa Radioimmunoassay Market Research Report – Segmented By Type, End User, Application & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis on Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 3560
Pages: 145

MEA RIA Market Size (2021 to 2026)

The size of the Middle East & Africa Radioimmunoassay Market was worth USD 36.72 million in 2021. It is further estimated to be growing at a CAGR of 3.18% and values USD 42.94 million by 2026.

The radioimmunoassay technique works on the principle of binding the assay. The binder is an antibody, which binds to the antigen, and the amount of antigen complex is measured by radioactivity. The radioimmunoassay has acquired significant importance in the field of medical diagnostics due to certain factors such as precision, accuracy, specificity of results, and sensitivity. However, the precision and sensitivity of the assay depend mainly on the quality of the antigens and antibodies collected and on the choice of separation techniques used. Therefore, radioimmunoassay kits are becoming increasingly popular as a vitro assay procedure in research institutes, diagnostic laboratories, pharmaceutical companies, the food and safety industry, and other healthcare establishments.

The wide applications of the radioimmunoassay technique, such as the radioimmunoassay to measure progesterone in cow's milk, early detection of cancer, autoimmune diseases, degenerative disorder, and drug reactivity, among others, are expected to fuel the demand for radioimmunoassay kits, which is anticipated to drive the MEA radioimmunoassay market in the upcoming years.

Growing research and development in the field of radioimmunoassay has given rise to newer products such as the immunoradiometric assay (IRMA), which is used with radiolabeled molecules and radioallergosorbent test (RAST), which is helpful to detect the causative allergen for a suspected allergy such as dust, pollen, medicine, and food substances, etc. Furthermore, with continuous study and evolution in the healthcare sector with an ever-changing list of diseases and allergens, the demand for radioimmunoassay is said to grow during the forecast period.

The presence of alternative methods that can be used to separate or identify or detect biomolecules will challenge the growth of the MEA radioimmunoassay market. In addition, the high cost of these kits can be a burden, and due to lack of funds and poor healthcare infrastructure in certain parts of Africa, the demand for radioimmunoassay can be affected, which is expected to restraint the overall market in the MEA region.

This research report on the Middle East and Africa radioimmunoassay market has been segmented and sub-segmented into the following categories:

By Type: 

  • Reagents and Kits
  • Analyzers

By End User: 

  • Hospitals
  • Pharmaceutical Industry and CRO
  • Clinical Diagnostic Laboratories

By Application: 

  • Research
  • Clinical Diagnostics

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Based on the region, the major countries in the region are UAE, Saudi Arabia, Qatar, Egypt, and South Africa. The region is the smallest market globally, with a growth rate that is also below average. The Middle East and Africa market is said to be dominated by the GCC countries such as the kingdom of Saudi Arabia, United Arab Emirates, Qatar, and Oman, etc., attributed to the advanced healthcare infrastructure, availability and widespread adoption of latest diagnostic technologies, large patient population, increased demand for hi-grade and accurate tests, availability of public and private funds for research sectors. The region is also home to many key market players with a manufacturing base for easy distribution of the products.

Meanwhile, the African and Sun-Saharan region is also analyzed to grow at a steady growth rate during the forecasted period, owing to main factors such as increasing incidence of cancer and allergies, increase in medical tourism, an increasing number of laboratories and medical centers, awareness about various disease and the growth of in-vitro diagnostics procedures in these countries is estimated to drive the development of the MEA radioimmunoassay market during the forecast period.


Companies playing a promising role in the Middle East & Africa radioimmunoassay market profiled in this report are DIAsource Immunoassays SA, Beckman Coulter, IBL International, PerkinElmer, DRG International, MP Biomedicals LLC, Cisbio, Euro Diagnostica AB, DiaSorin S.p. A, EMD Millipore, Izotop, Berthold Technologies GmbH & Co. KG and Stratec Biomedical AG.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Type                              

                                5.1.1 Introduction           

                                5.1.2 Reagents and Kits                

                                5.1.3 Analyzers 

                                5.1.4  Y-o-Y Growth Analysis, By Type    

                                5.1.5  Market Attractiveness Analysis, By Type  

                                5.1.6  Market Share Analysis, By Type    

                5.2 End User                      

                                5.2.1 Introduction           

                                5.2.2 Hospital    

                                5.2.3 Pharmaceutical Industry and CRO 

                                5.2.4 Clinical Diagnostic Laboratories       

                                5.2.5 Y-o-Y Growth Analysis, By End User             

                                5.2.6 Market Attractiveness Analysis, By End User           

                                5.2.7 Market Share Analysis, By End User             

                5.3 Application                 

                                5.3.1 Introduction           

                                5.3.2 Research  

                                5.3.3 Clinical Diagnostics               

                                5.3.4 Y-o-Y Growth Analysis, By Application         

                                5.3.5  Market Attractiveness Analysis, By Application      

                                5.3.6  Market Share Analysis, By Application       

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                       By Geographical Area

                                       By Type

                                       By End User

                                       By Application

                                6.1.4  Market Attractiveness Analysis     

                                       By Geographical Area

                                       By Type

                                       By End User

                                       By Application

                                6.1.5  Market Share Analysis      

                                       By Geographical Area

                                       By Type

                                       By End User

                                       By Application

                6.2 Middle-East                                

                6.3 Africa                            

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 DIAsource ImmunoAssays SA                             

                                8.1.1 Overview 

                                8.1.2 Type Analysis         

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Beckman Coulter                     

                8.3 IBL International                       

                8.4 PerkinElmer                               

                8.5 DRG international                    

                8.6 MP Biomedicals                        

                8.7 Cisbio                            

                8.8 Euro Diagnostica AB                

                8.9 DiaSorin                       

                8.10 Stratec Biomedical                

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         


                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East and Africa Radioimmunoassay Market, By Type, From 2021 to 2026 (USD Million)
  2. Middle East and Africa Reagents and Kits Market, By Region, From 2021 to 2026 (USD Million)
  3. Middle East and Africa Analyzers Market, By Region, From 2021 to 2026 (USD Million)
  4. Middle East and Africa Radioimmunoassay Market, By End User, From 2021 to 2026 (USD Million)
  5. Middle East and Africa Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  6. Middle East and Africa Pharmaceutical Industry and CRO Market, By Region, From 2021 to 2026 (USD Million)
  7. Middle East and Africa Academics Market, By Region, From 2021 to 2026 (USD Million)
  8. Middle East and Africa Clinical Diagnostic Laboratories Market, By Region, From 2021 to 2026 (USD Million)
  9. Middle East and Africa Radioimmunoassay Market, By Application, From 2021 to 2026 (USD Million)
  10. Middle East and Africa Research Market, By Region, From 2021 to 2026 (USD Million)
  11. Middle East and Africa Clinical Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  12. Middle East Radioimmunoassay Market, By Type, From 2021 to 2026 (USD Million)
  13. Middle East Radioimmunoassay Market, By End User, From 2021 to 2026 (USD Million)
  14. Middle East Radioimmunoassay Market, By Application, From 2021 to 2026 (USD Million)
  15. Africa Radioimmunoassay Market, By Type, From 2021 to 2026 (USD Million)
  16. Africa Radioimmunoassay Market, By End User, From 2021 to 2026 (USD Million)
  17. Africa Radioimmunoassay Market, By Application, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports


$ 1234 2875

Click for Request Sample